NLRP3 and Cognitive impairment: Serum antibodies against F. nucleatum are highly expressed in AD patient brains and promote microglial TNF-α release through nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3 (NLRP3) inflammasome activation, thus triggering inflammatory responses that worsen cognitive impairment [87,88].